Concepts (301)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastrointestinal Microbiome | 15 | 2026 | 267 | 6.740 |
Why?
|
| Stress Disorders, Post-Traumatic | 34 | 2026 | 406 | 5.210 |
Why?
|
| Microbiota | 7 | 2025 | 170 | 3.830 |
Why?
|
| Alzheimer Disease | 8 | 2026 | 768 | 2.840 |
Why?
|
| Dysbiosis | 7 | 2024 | 74 | 2.670 |
Why?
|
| Frailty | 4 | 2022 | 132 | 2.230 |
Why?
|
| Feces | 6 | 2024 | 118 | 2.210 |
Why?
|
| Anti-Bacterial Agents | 8 | 2022 | 807 | 1.830 |
Why?
|
| Emergency Service, Hospital | 17 | 2026 | 1163 | 1.780 |
Why?
|
| Soft Tissue Infections | 4 | 2020 | 48 | 1.590 |
Why?
|
| Drug Resistance, Bacterial | 3 | 2020 | 97 | 1.560 |
Why?
|
| Asymptomatic Infections | 2 | 2025 | 29 | 1.540 |
Why?
|
| Cognitive Dysfunction | 4 | 2026 | 351 | 1.530 |
Why?
|
| Bacteria | 6 | 2026 | 337 | 1.530 |
Why?
|
| Urinary Tract Infections | 2 | 2025 | 97 | 1.520 |
Why?
|
| Nursing Homes | 6 | 2024 | 692 | 1.230 |
Why?
|
| Aging | 3 | 2026 | 775 | 1.130 |
Why?
|
| Clostridium Infections | 2 | 2021 | 49 | 1.130 |
Why?
|
| Aged | 29 | 2026 | 15089 | 1.100 |
Why?
|
| Metagenomics | 3 | 2024 | 29 | 1.060 |
Why?
|
| Humans | 82 | 2026 | 65646 | 1.040 |
Why?
|
| Male | 51 | 2026 | 31295 | 1.010 |
Why?
|
| Female | 53 | 2026 | 34309 | 0.980 |
Why?
|
| Enterocolitis, Pseudomembranous | 2 | 2016 | 33 | 0.890 |
Why?
|
| Urine | 1 | 2025 | 47 | 0.890 |
Why?
|
| Diarrhea | 2 | 2016 | 73 | 0.880 |
Why?
|
| Pneumonia, Bacterial | 2 | 2018 | 91 | 0.870 |
Why?
|
| Middle Aged | 39 | 2026 | 18439 | 0.860 |
Why?
|
| Adult | 43 | 2026 | 17511 | 0.850 |
Why?
|
| Inflammation | 5 | 2026 | 1195 | 0.830 |
Why?
|
| Prospective Studies | 17 | 2026 | 3329 | 0.810 |
Why?
|
| Weevils | 1 | 2023 | 1 | 0.810 |
Why?
|
| Tumor Microenvironment | 1 | 2025 | 183 | 0.800 |
Why?
|
| Cognition | 3 | 2026 | 511 | 0.790 |
Why?
|
| Survivors | 6 | 2026 | 187 | 0.770 |
Why?
|
| Influenza, Human | 3 | 2014 | 210 | 0.740 |
Why?
|
| Guideline Adherence | 3 | 2020 | 310 | 0.720 |
Why?
|
| Aged, 80 and over | 11 | 2026 | 5656 | 0.690 |
Why?
|
| Treatment Failure | 3 | 2021 | 208 | 0.670 |
Why?
|
| Longitudinal Studies | 15 | 2026 | 1288 | 0.640 |
Why?
|
| Young Adult | 23 | 2026 | 4855 | 0.630 |
Why?
|
| Fear | 3 | 2025 | 71 | 0.610 |
Why?
|
| Skin Diseases, Infectious | 2 | 2016 | 12 | 0.600 |
Why?
|
| Polysaccharides | 1 | 2021 | 155 | 0.590 |
Why?
|
| Inappropriate Prescribing | 1 | 2020 | 68 | 0.590 |
Why?
|
| Biomarkers | 8 | 2026 | 1487 | 0.590 |
Why?
|
| White Matter | 3 | 2025 | 128 | 0.580 |
Why?
|
| C-Reactive Protein | 2 | 2026 | 169 | 0.570 |
Why?
|
| Macrolides | 1 | 2018 | 38 | 0.540 |
Why?
|
| Alcohol Drinking | 3 | 2025 | 325 | 0.540 |
Why?
|
| Magnetic Resonance Imaging | 11 | 2026 | 2262 | 0.530 |
Why?
|
| Antacids | 1 | 2017 | 14 | 0.530 |
Why?
|
| Community-Acquired Infections | 1 | 2018 | 95 | 0.520 |
Why?
|
| Independent Living | 1 | 2017 | 55 | 0.510 |
Why?
|
| Bacterial Infections | 2 | 2023 | 150 | 0.510 |
Why?
|
| Nutritional Status | 1 | 2017 | 101 | 0.510 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 809 | 0.500 |
Why?
|
| Wounds and Injuries | 3 | 2026 | 250 | 0.480 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2017 | 182 | 0.470 |
Why?
|
| Cohort Studies | 9 | 2025 | 2639 | 0.470 |
Why?
|
| Cytokines | 2 | 2026 | 964 | 0.460 |
Why?
|
| Skin Diseases, Bacterial | 1 | 2015 | 8 | 0.460 |
Why?
|
| Psychological Trauma | 3 | 2026 | 23 | 0.460 |
Why?
|
| Outpatients | 1 | 2016 | 143 | 0.460 |
Why?
|
| Tobacco Use | 2 | 2025 | 42 | 0.440 |
Why?
|
| Marijuana Use | 2 | 2025 | 23 | 0.430 |
Why?
|
| Mediator Complex | 1 | 2014 | 13 | 0.430 |
Why?
|
| Hyphae | 1 | 2014 | 17 | 0.430 |
Why?
|
| Health Personnel | 3 | 2025 | 390 | 0.430 |
Why?
|
| Neoplasms | 1 | 2025 | 1376 | 0.430 |
Why?
|
| Hemagglutinins, Viral | 1 | 2014 | 11 | 0.420 |
Why?
|
| Acute Pain | 2 | 2026 | 20 | 0.420 |
Why?
|
| Resilience, Psychological | 2 | 2026 | 66 | 0.420 |
Why?
|
| Candida albicans | 1 | 2014 | 61 | 0.420 |
Why?
|
| Administration, Intravenous | 1 | 2014 | 78 | 0.410 |
Why?
|
| RNA, Ribosomal, 16S | 4 | 2023 | 106 | 0.410 |
Why?
|
| Reward | 2 | 2024 | 89 | 0.410 |
Why?
|
| Fungal Proteins | 1 | 2014 | 153 | 0.400 |
Why?
|
| Brain Injuries, Traumatic | 2 | 2026 | 96 | 0.400 |
Why?
|
| Residence Characteristics | 2 | 2026 | 230 | 0.400 |
Why?
|
| Smartphone | 2 | 2026 | 75 | 0.400 |
Why?
|
| Antibodies, Viral | 2 | 2023 | 327 | 0.400 |
Why?
|
| Sex Characteristics | 2 | 2026 | 214 | 0.390 |
Why?
|
| Respiratory Tract Infections | 1 | 2014 | 90 | 0.390 |
Why?
|
| Chronic Pain | 2 | 2026 | 157 | 0.390 |
Why?
|
| Wearable Electronic Devices | 2 | 2024 | 78 | 0.380 |
Why?
|
| Heart Rate | 2 | 2024 | 334 | 0.370 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2026 | 89 | 0.370 |
Why?
|
| Accidents, Traffic | 6 | 2022 | 140 | 0.360 |
Why?
|
| Diffusion Tensor Imaging | 4 | 2026 | 78 | 0.350 |
Why?
|
| Severity of Illness Index | 5 | 2026 | 1567 | 0.350 |
Why?
|
| Virus Diseases | 1 | 2012 | 117 | 0.340 |
Why?
|
| Machine Learning | 3 | 2024 | 196 | 0.340 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2022 | 710 | 0.340 |
Why?
|
| Amygdala | 3 | 2024 | 85 | 0.300 |
Why?
|
| Prefrontal Cortex | 3 | 2024 | 128 | 0.290 |
Why?
|
| Risk Factors | 8 | 2025 | 5466 | 0.290 |
Why?
|
| Practice Guidelines as Topic | 3 | 2020 | 741 | 0.290 |
Why?
|
| Wrist | 3 | 2024 | 39 | 0.290 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2026 | 42 | 0.280 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 3 | 2014 | 86 | 0.280 |
Why?
|
| Depression | 7 | 2023 | 908 | 0.270 |
Why?
|
| Pain | 3 | 2023 | 400 | 0.270 |
Why?
|
| Brain | 7 | 2024 | 1625 | 0.270 |
Why?
|
| Motor Vehicles | 6 | 2023 | 32 | 0.260 |
Why?
|
| Hippocampus | 2 | 2026 | 277 | 0.250 |
Why?
|
| Adolescent | 9 | 2026 | 6350 | 0.240 |
Why?
|
| Presenteeism | 1 | 2025 | 5 | 0.240 |
Why?
|
| Air Pollution | 1 | 2026 | 42 | 0.230 |
Why?
|
| Wakefulness | 1 | 2026 | 44 | 0.230 |
Why?
|
| Bacteriuria | 1 | 2025 | 16 | 0.230 |
Why?
|
| Urinalysis | 1 | 2025 | 37 | 0.230 |
Why?
|
| Basolateral Nuclear Complex | 1 | 2025 | 8 | 0.220 |
Why?
|
| Sleep | 2 | 2026 | 245 | 0.220 |
Why?
|
| Gene-Environment Interaction | 1 | 2025 | 54 | 0.220 |
Why?
|
| Galvanic Skin Response | 1 | 2025 | 25 | 0.220 |
Why?
|
| Autonomic Nervous System | 1 | 2025 | 35 | 0.220 |
Why?
|
| Prognosis | 3 | 2025 | 1791 | 0.220 |
Why?
|
| Equol | 1 | 2024 | 5 | 0.220 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2025 | 47 | 0.220 |
Why?
|
| ROC Curve | 3 | 2021 | 294 | 0.220 |
Why?
|
| Mouth | 1 | 2024 | 36 | 0.210 |
Why?
|
| Binge Drinking | 1 | 2025 | 39 | 0.210 |
Why?
|
| Animals | 8 | 2025 | 21465 | 0.210 |
Why?
|
| Metabolomics | 1 | 2024 | 64 | 0.210 |
Why?
|
| Mobile Applications | 1 | 2026 | 142 | 0.210 |
Why?
|
| Pollination | 1 | 2023 | 3 | 0.200 |
Why?
|
| Income | 1 | 2025 | 169 | 0.200 |
Why?
|
| Flowers | 1 | 2023 | 4 | 0.200 |
Why?
|
| Estradiol | 1 | 2025 | 260 | 0.200 |
Why?
|
| Massachusetts | 3 | 2024 | 2154 | 0.200 |
Why?
|
| Symbiosis | 1 | 2023 | 36 | 0.200 |
Why?
|
| Plants | 1 | 2023 | 50 | 0.200 |
Why?
|
| Gray Matter | 1 | 2023 | 39 | 0.200 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 931 | 0.190 |
Why?
|
| Internal Capsule | 1 | 2023 | 11 | 0.190 |
Why?
|
| Longevity | 1 | 2024 | 119 | 0.190 |
Why?
|
| Adult Survivors of Child Abuse | 1 | 2023 | 13 | 0.190 |
Why?
|
| Computational Biology | 1 | 2025 | 368 | 0.190 |
Why?
|
| Biological Availability | 1 | 2023 | 210 | 0.190 |
Why?
|
| Dreams | 1 | 2022 | 3 | 0.190 |
Why?
|
| Epigenesis, Genetic | 1 | 2026 | 408 | 0.190 |
Why?
|
| Dissociative Disorders | 1 | 2022 | 8 | 0.180 |
Why?
|
| Cannabis | 1 | 2023 | 54 | 0.180 |
Why?
|
| Prevalence | 3 | 2021 | 1453 | 0.180 |
Why?
|
| Phylogeny | 1 | 2023 | 399 | 0.180 |
Why?
|
| Logistic Models | 2 | 2016 | 1273 | 0.180 |
Why?
|
| Sex Factors | 3 | 2025 | 995 | 0.180 |
Why?
|
| Alcoholism | 1 | 2025 | 329 | 0.180 |
Why?
|
| Child Abuse | 1 | 2023 | 89 | 0.180 |
Why?
|
| Insulins | 1 | 2022 | 15 | 0.180 |
Why?
|
| Functional Neuroimaging | 1 | 2021 | 16 | 0.180 |
Why?
|
| Social Support | 1 | 2024 | 394 | 0.170 |
Why?
|
| Blood Pressure | 1 | 2024 | 535 | 0.170 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 169 | 0.170 |
Why?
|
| Fatty Acids, Volatile | 1 | 2021 | 22 | 0.170 |
Why?
|
| Abscess | 1 | 2021 | 79 | 0.170 |
Why?
|
| Human Development | 1 | 2020 | 9 | 0.170 |
Why?
|
| Health | 1 | 2020 | 30 | 0.160 |
Why?
|
| Drainage | 1 | 2021 | 153 | 0.160 |
Why?
|
| Proton Pump Inhibitors | 1 | 2021 | 47 | 0.160 |
Why?
|
| Virus Replication | 1 | 2002 | 323 | 0.160 |
Why?
|
| Diet | 1 | 2024 | 536 | 0.160 |
Why?
|
| Monocytes | 1 | 2002 | 361 | 0.150 |
Why?
|
| Models, Theoretical | 1 | 2021 | 274 | 0.150 |
Why?
|
| Stress Disorders, Traumatic | 1 | 2019 | 8 | 0.150 |
Why?
|
| Sleep Wake Disorders | 1 | 2021 | 82 | 0.150 |
Why?
|
| United States | 6 | 2026 | 8166 | 0.150 |
Why?
|
| Psychometrics | 1 | 2021 | 396 | 0.150 |
Why?
|
| Anxiety | 4 | 2023 | 427 | 0.150 |
Why?
|
| Self Care | 1 | 2021 | 218 | 0.150 |
Why?
|
| Occupational Diseases | 1 | 2021 | 266 | 0.140 |
Why?
|
| Ambulatory Care | 1 | 2021 | 318 | 0.140 |
Why?
|
| Intestines | 1 | 2019 | 184 | 0.130 |
Why?
|
| Paracentesis | 1 | 2016 | 12 | 0.120 |
Why?
|
| HIV-1 | 1 | 2002 | 706 | 0.120 |
Why?
|
| Cross-Sectional Studies | 4 | 2025 | 2730 | 0.120 |
Why?
|
| Disease Models, Animal | 2 | 2022 | 2327 | 0.120 |
Why?
|
| Epithelial Cells | 1 | 2019 | 414 | 0.120 |
Why?
|
| Homeostasis | 1 | 2019 | 383 | 0.120 |
Why?
|
| Multicenter Studies as Topic | 1 | 2016 | 161 | 0.120 |
Why?
|
| Age Distribution | 1 | 2016 | 262 | 0.120 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 413 | 0.120 |
Why?
|
| Recurrence | 1 | 2017 | 664 | 0.120 |
Why?
|
| Telemedicine | 1 | 2021 | 376 | 0.120 |
Why?
|
| Substance-Related Disorders | 1 | 2023 | 756 | 0.110 |
Why?
|
| Sensitivity and Specificity | 2 | 2023 | 1172 | 0.110 |
Why?
|
| Dementia | 1 | 2019 | 285 | 0.110 |
Why?
|
| HIV Infections | 1 | 2002 | 958 | 0.110 |
Why?
|
| Opioid-Related Disorders | 1 | 2022 | 531 | 0.110 |
Why?
|
| Case-Control Studies | 3 | 2023 | 1144 | 0.110 |
Why?
|
| Hemagglutination Inhibition Tests | 1 | 2014 | 9 | 0.110 |
Why?
|
| Algorithms | 1 | 2020 | 1052 | 0.100 |
Why?
|
| Virulence | 1 | 2014 | 199 | 0.100 |
Why?
|
| Antibody Formation | 1 | 2014 | 111 | 0.100 |
Why?
|
| HLA-DR3 Antigen | 1 | 2013 | 7 | 0.100 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2014 | 127 | 0.100 |
Why?
|
| Mental Disorders | 1 | 2021 | 825 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2014 | 297 | 0.100 |
Why?
|
| Femoral Nerve | 1 | 2013 | 10 | 0.100 |
Why?
|
| Administration, Oral | 1 | 2014 | 371 | 0.100 |
Why?
|
| Morphine | 1 | 2013 | 61 | 0.100 |
Why?
|
| Escherichia coli | 1 | 2017 | 717 | 0.090 |
Why?
|
| Psychopathology | 2 | 2023 | 22 | 0.090 |
Why?
|
| Statistics, Nonparametric | 1 | 2013 | 213 | 0.090 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2013 | 186 | 0.090 |
Why?
|
| Odds Ratio | 1 | 2014 | 757 | 0.090 |
Why?
|
| Influenza Vaccines | 1 | 2013 | 99 | 0.090 |
Why?
|
| Antibodies, Neutralizing | 1 | 2014 | 218 | 0.090 |
Why?
|
| Nerve Block | 1 | 2013 | 62 | 0.090 |
Why?
|
| Hip Fractures | 1 | 2013 | 78 | 0.090 |
Why?
|
| Trauma Centers | 1 | 2012 | 130 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2012 | 606 | 0.080 |
Why?
|
| Age Factors | 1 | 2015 | 1592 | 0.080 |
Why?
|
| Pain Management | 1 | 2013 | 174 | 0.080 |
Why?
|
| Anxiety Disorders | 2 | 2023 | 201 | 0.080 |
Why?
|
| Retrospective Studies | 3 | 2021 | 6948 | 0.080 |
Why?
|
| Treatment Outcome | 1 | 2021 | 5820 | 0.080 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 992 | 0.080 |
Why?
|
| Neuroimaging | 2 | 2022 | 165 | 0.080 |
Why?
|
| Emergency Medical Services | 1 | 2013 | 264 | 0.080 |
Why?
|
| Disease Progression | 1 | 2014 | 1227 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2013 | 642 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 1116 | 0.070 |
Why?
|
| Delivery of Health Care | 2 | 2023 | 439 | 0.070 |
Why?
|
| Infant, Newborn | 2 | 2023 | 1437 | 0.070 |
Why?
|
| Paecilomyces | 1 | 2008 | 2 | 0.070 |
Why?
|
| Bursitis | 1 | 2008 | 18 | 0.070 |
Why?
|
| Mycoses | 1 | 2008 | 65 | 0.060 |
Why?
|
| Mutation | 1 | 2014 | 2670 | 0.060 |
Why?
|
| Interleukin-8 | 1 | 2026 | 96 | 0.060 |
Why?
|
| Child | 3 | 2022 | 4634 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2023 | 1291 | 0.060 |
Why?
|
| Ultrasonography | 2 | 2021 | 491 | 0.060 |
Why?
|
| Multifactorial Inheritance | 1 | 2025 | 26 | 0.060 |
Why?
|
| Particulate Matter | 1 | 2026 | 72 | 0.060 |
Why?
|
| Reflex, Startle | 1 | 2025 | 7 | 0.060 |
Why?
|
| Interleukin-10 | 1 | 2026 | 165 | 0.060 |
Why?
|
| Air Pollutants | 1 | 2026 | 100 | 0.050 |
Why?
|
| Pain Measurement | 1 | 2026 | 344 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2026 | 323 | 0.050 |
Why?
|
| Vaccines, Combined | 1 | 2023 | 9 | 0.050 |
Why?
|
| Hypothalamus | 1 | 2024 | 135 | 0.050 |
Why?
|
| Hydroxy Acids | 1 | 2023 | 2 | 0.050 |
Why?
|
| Bacteroides fragilis | 1 | 2023 | 5 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2025 | 626 | 0.050 |
Why?
|
| Bacteroides | 1 | 2023 | 10 | 0.050 |
Why?
|
| Dinoprostone | 1 | 2023 | 42 | 0.050 |
Why?
|
| Analgesics, Opioid | 2 | 2022 | 530 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2026 | 604 | 0.050 |
Why?
|
| Anisotropy | 1 | 2023 | 63 | 0.050 |
Why?
|
| Nucleocapsid Proteins | 1 | 2023 | 34 | 0.050 |
Why?
|
| Seroepidemiologic Studies | 1 | 2023 | 51 | 0.050 |
Why?
|
| Gyrus Cinguli | 1 | 2023 | 59 | 0.050 |
Why?
|
| Cerebral Cortex | 1 | 2024 | 270 | 0.050 |
Why?
|
| Neuropsychological Tests | 1 | 2024 | 414 | 0.050 |
Why?
|
| Nerve Net | 1 | 2023 | 103 | 0.050 |
Why?
|
| Socioeconomic Factors | 1 | 2025 | 805 | 0.050 |
Why?
|
| Mice | 3 | 2023 | 11174 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2002 | 104 | 0.040 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2023 | 114 | 0.040 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2022 | 28 | 0.040 |
Why?
|
| Biological Variation, Individual | 1 | 2021 | 2 | 0.040 |
Why?
|
| Precipitating Factors | 1 | 2021 | 3 | 0.040 |
Why?
|
| Psychophysiology | 1 | 2021 | 7 | 0.040 |
Why?
|
| Plaque, Amyloid | 1 | 2022 | 42 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2023 | 449 | 0.040 |
Why?
|
| Trauma Severity Indices | 1 | 2021 | 33 | 0.040 |
Why?
|
| Rats | 1 | 2025 | 2002 | 0.040 |
Why?
|
| Comorbidity | 1 | 2025 | 1120 | 0.040 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2022 | 83 | 0.040 |
Why?
|
| Immunization, Secondary | 1 | 2021 | 52 | 0.040 |
Why?
|
| Life Change Events | 1 | 2021 | 66 | 0.040 |
Why?
|
| Immunization Schedule | 1 | 2021 | 22 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2023 | 472 | 0.040 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2021 | 382 | 0.040 |
Why?
|
| Self Report | 1 | 2023 | 394 | 0.040 |
Why?
|
| Microglia | 1 | 2023 | 254 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2021 | 514 | 0.040 |
Why?
|
| Vaccination | 1 | 2023 | 388 | 0.040 |
Why?
|
| Emotions | 1 | 2022 | 235 | 0.040 |
Why?
|
| Military Personnel | 1 | 2019 | 110 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2021 | 363 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2023 | 1581 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2023 | 2789 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2021 | 2113 | 0.030 |
Why?
|
| Hospitals, Urban | 1 | 2013 | 44 | 0.030 |
Why?
|
| Infusions, Parenteral | 1 | 2013 | 23 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2013 | 237 | 0.020 |
Why?
|
| New England | 1 | 2013 | 271 | 0.020 |
Why?
|
| Analgesia | 1 | 2013 | 37 | 0.020 |
Why?
|
| Viral Load | 1 | 2013 | 230 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2013 | 183 | 0.020 |
Why?
|
| Veterans | 1 | 2019 | 767 | 0.020 |
Why?
|
| Quality of Health Care | 1 | 2013 | 533 | 0.020 |
Why?
|
| Infant | 1 | 2013 | 1711 | 0.020 |
Why?
|
| Lung | 1 | 2013 | 969 | 0.020 |
Why?
|
| Drug Resistance, Multiple, Fungal | 1 | 2008 | 4 | 0.020 |
Why?
|
| Ketoconazole | 1 | 2008 | 11 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2013 | 2076 | 0.020 |
Why?
|
| Immunocompromised Host | 1 | 2008 | 104 | 0.020 |
Why?
|